Advertisement
Screener

Alaunos Therapeutics, Inc. (TCRT) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

1.5 / 5 stars · 19/64 Roast Me

Alaunos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

Alaunos Therapeutics, Inc. (TCRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 1.84 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-14

  • Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
  • Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 1.84K shares.
  • Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 3.07K shares.
  • Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 3.58K shares.
  • Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 7.33K shares, a 72.48% decline from fiscal 2024.
  • Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 26.64K shares, a 45.31% decline from fiscal 2023.
  • Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 48.71K shares, a 85.17% decline from fiscal 2022.
  • Alaunos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 328.57K shares, a 93.67% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
1.84K shares
10-Q · filed 2026-08-14
4.90K shares
derived: sum of 3 quarters · filed 2026-08-14
8.48K shares
derived: sum of 4 quarters · filed 2026-08-14
2026-03-311.84K shares
10-Q · filed 2026-05-15
4.90K shares
derived: sum of 2 quarters · filed 2026-05-15
8.48K shares
derived: sum of 3 quarters · filed 2026-05-15
9.17K shares
derived: sum of 4 quarters · filed 2026-05-15
2025-12-313.07K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
6.65K shares
derived: sum of 2 quarters · filed 2026-03-31
7.33K shares
derived: sum of 3 quarters · filed 2026-03-31
7.33K shares
10-K · filed 2026-03-31
2025-09-303.58K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
4.26K shares
derived: sum of 2 quarters · filed 2025-11-14
4.26K shares
10-Q · filed 2025-11-14
4.26K shares
derived: sum of 4 quarters · filed 2025-11-14
2025-06-30686.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
686.00 shares
10-Q · filed 2025-08-14
686.00 shares
derived: sum of 3 quarters · filed 2025-08-14
686.00 shares
derived: sum of 4 quarters · filed 2025-08-14
2025-03-310.00 shares
10-Q · filed 2025-05-15
0.00 shares
derived: sum of 2 quarters · filed 2025-05-15
0.00 shares
derived: sum of 3 quarters · filed 2025-05-15
-227.80K shares
derived: sum of 4 quarters · filed 2025-05-15
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
0.00 shares
derived: sum of 2 quarters · filed 2025-03-31
-227.80K shares
derived: sum of 3 quarters · filed 2025-03-31
26.64K shares
10-K · filed 2025-03-31
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-227.80K shares
derived: sum of 2 quarters · filed 2024-11-14
26.64K shares
10-Q · filed 2024-11-14
-1.61M shares
derived: sum of 4 quarters · filed 2025-03-31
2024-06-30-227.80K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
26.64K shares
10-Q · filed 2024-08-14
-1.61M shares
derived: sum of 3 quarters · filed 2025-03-31
-409.55K shares
derived: sum of 4 quarters · filed 2025-03-31
2024-03-31254.44K shares
10-Q · filed 2024-05-15
-1.38M shares
derived: sum of 2 quarters · filed 2025-03-31
-181.75K shares
derived: sum of 3 quarters · filed 2025-03-31
142.61K shares
derived: sum of 4 quarters · filed 2025-03-31
2023-12-31-1.64M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-436.19K shares
derived: sum of 2 quarters · filed 2025-03-31
-111.83K shares
derived: sum of 3 quarters · filed 2025-03-31
48.71K shares
10-K · filed 2025-03-31
487.13K shares
10-K · filed 2024-04-01
2023-09-301.20M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
1.53M shares
derived: sum of 2 quarters · filed 2023-11-14
1.69M shares
10-Q · filed 2023-11-14
-2.67M shares
derived: sum of 4 quarters · filed 2024-04-01
2023-06-30324.36K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
484.90K shares
10-Q · filed 2023-08-14
-3.87M shares
derived: sum of 3 quarters · filed 2024-04-01
-3.15M shares
derived: sum of 4 quarters · filed 2024-04-01
2023-03-31160.54K shares
10-Q · filed 2023-05-10
-4.19M shares
derived: sum of 2 quarters · filed 2024-04-01
-3.47M shares
derived: sum of 3 quarters · filed 2024-04-01
-1.90M shares
derived: sum of 4 quarters · filed 2024-04-01
2022-12-31-4.36M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-3.63M shares
derived: sum of 2 quarters · filed 2024-04-01
-2.06M shares
derived: sum of 3 quarters · filed 2024-04-01
328.57K shares
10-K · filed 2024-04-01
4.93M shares
10-K · filed 2023-03-07
2022-09-30722.17K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
2.30M shares
derived: sum of 2 quarters · filed 2022-11-14
4.68M shares
10-Q · filed 2022-11-14
7.32M shares
derived: sum of 4 quarters · filed 2023-03-07
2022-06-301.58M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
3.96M shares
10-Q · filed 2022-08-15
6.60M shares
derived: sum of 3 quarters · filed 2023-03-07
8.47M shares
derived: sum of 4 quarters · filed 2023-03-07
2022-03-312.39M shares
10-Q · filed 2022-05-16
5.02M shares
derived: sum of 2 quarters · filed 2023-03-07
6.89M shares
derived: sum of 3 quarters · filed 2023-03-07
7.49M shares
derived: sum of 4 quarters · filed 2023-03-07
2021-12-312.64M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07
4.51M shares
derived: sum of 2 quarters · filed 2023-03-07
5.11M shares
derived: sum of 3 quarters · filed 2023-03-07
5.19M shares
10-K · filed 2023-03-07
2021-09-301.87M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
2.47M shares
derived: sum of 2 quarters · filed 2021-11-08
2.56M shares
10-Q · filed 2021-11-08
2.94M shares
derived: sum of 4 quarters · filed 2022-03-30
2021-06-30601.88K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
686.22K shares
10-Q · filed 2021-08-13
1.07M shares
derived: sum of 3 quarters · filed 2022-03-30
1.25M shares
derived: sum of 4 quarters · filed 2022-03-30
2021-03-3184.34K shares
10-Q · filed 2021-05-06
470.58K shares
derived: sum of 2 quarters · filed 2022-03-30
648.33K shares
derived: sum of 3 quarters · filed 2022-03-30
910.87K shares
derived: sum of 4 quarters · filed 2022-03-30
2020-12-31386.25K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
564.00K shares
derived: sum of 2 quarters · filed 2022-03-30
826.53K shares
derived: sum of 3 quarters · filed 2022-03-30
886.20K shares
10-K · filed 2022-03-30
894.53K shares
10-K · filed 2021-03-01
2020-09-30177.75K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
440.28K shares
derived: sum of 2 quarters · filed 2020-11-05
499.95K shares
10-Q · filed 2020-11-05
598.95K shares
derived: sum of 4 quarters · filed 2021-03-01
2020-06-30262.53K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
322.20K shares
10-Q · filed 2020-08-06
421.20K shares
derived: sum of 3 quarters · filed 2021-03-01
493.16K shares
derived: sum of 4 quarters · filed 2021-03-01
2020-03-3159.67K shares
10-Q · filed 2020-05-07
158.67K shares
derived: sum of 2 quarters · filed 2021-03-01
230.63K shares
derived: sum of 3 quarters · filed 2021-03-01
436.13K shares
derived: sum of 4 quarters · filed 2021-03-01
2019-12-3199.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
170.96K shares
derived: sum of 2 quarters · filed 2021-03-01
376.46K shares
derived: sum of 3 quarters · filed 2021-03-01
1.73M shares
10-K · filed 2021-03-01
2019-09-3071.96K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
277.46K shares
derived: sum of 2 quarters · filed 2019-11-07
1.63M shares
10-Q · filed 2019-11-07
1.67M shares
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30205.50K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
1.56M shares
10-Q · filed 2019-08-08
1.59M shares
derived: sum of 3 quarters · filed 2021-03-01
1.63M shares
derived: sum of 4 quarters · filed 2021-03-01
2019-03-311.36M shares
10-Q · filed 2019-05-08
1.39M shares
derived: sum of 2 quarters · filed 2021-03-01
1.42M shares
derived: sum of 3 quarters · filed 2021-03-01
1.54M shares
derived: sum of 4 quarters · filed 2021-03-01
2018-12-3131.33K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
66.17K shares
derived: sum of 2 quarters · filed 2021-03-01
179.17K shares
derived: sum of 3 quarters · filed 2021-03-01
215.83K shares
10-K · filed 2021-03-01
2018-09-3034.83K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
147.83K shares
derived: sum of 2 quarters · filed 2018-11-09
184.50K shares
10-Q · filed 2018-11-09
184.50K shares
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30113.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
149.67K shares
10-Q · filed 2018-08-08
149.67K shares
derived: sum of 3 quarters · filed 2020-03-02
158.67K shares
derived: sum of 4 quarters · filed 2020-03-02
2018-03-3136.67K shares
10-Q · filed 2018-05-10
36.67K shares
derived: sum of 2 quarters · filed 2020-03-02
45.67K shares
derived: sum of 3 quarters · filed 2020-03-02
121.00K shares
derived: sum of 4 quarters · filed 2020-03-02
2017-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
9.00K shares
derived: sum of 2 quarters · filed 2020-03-02
84.33K shares
derived: sum of 3 quarters · filed 2020-03-02
122.00K shares
10-K · filed 2020-03-02
2017-09-309.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
84.33K shares
derived: sum of 2 quarters · filed 2017-11-06
122.00K shares
10-Q · filed 2017-11-06
244.40K shares
derived: sum of 4 quarters · filed 2019-03-05
2017-06-3075.33K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31
113.00K shares
10-Q · filed 2017-07-31
235.40K shares
derived: sum of 3 quarters · filed 2019-03-05
246.73K shares
derived: sum of 4 quarters · filed 2019-03-05
2017-03-3137.67K shares
10-Q · filed 2017-05-01
160.07K shares
derived: sum of 2 quarters · filed 2019-03-05
171.40K shares
derived: sum of 3 quarters · filed 2019-03-05
178.43K shares
derived: sum of 4 quarters · filed 2019-03-05
2016-12-31122.40K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05
133.73K shares
derived: sum of 2 quarters · filed 2019-03-05
140.77K shares
derived: sum of 3 quarters · filed 2019-03-05
144.10K shares
10-K · filed 2019-03-05
2016-09-3011.33K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
18.37K shares
derived: sum of 2 quarters · filed 2016-11-09
21.70K shares
10-Q · filed 2016-11-09
57.37K shares
derived: sum of 4 quarters · filed 2018-03-01
2016-06-307.03K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
10.37K shares
10-Q · filed 2016-08-09
46.03K shares
derived: sum of 3 quarters · filed 2018-03-01
59.37K shares
derived: sum of 4 quarters · filed 2018-03-01
2016-03-313.33K shares
10-Q · filed 2016-05-10
39.00K shares
derived: sum of 2 quarters · filed 2018-03-01
52.34K shares
derived: sum of 3 quarters · filed 2018-03-01
167.00K shares
derived: sum of 4 quarters · filed 2018-03-01
2015-12-3135.67K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
49.00K shares
derived: sum of 2 quarters · filed 2018-03-01
163.67K shares
derived: sum of 3 quarters · filed 2018-03-01
202.84K shares
10-K · filed 2018-03-01
2015-09-3013.33K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
128.00K shares
derived: sum of 2 quarters · filed 2015-11-02
167.17K shares
10-Q · filed 2015-11-02
411.43K shares
derived: sum of 4 quarters · filed 2017-02-16
2015-06-30114.67K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
153.83K shares
10-Q · filed 2015-08-10
398.10K shares
derived: sum of 3 quarters · filed 2017-02-16
654.23K shares
derived: sum of 4 quarters · filed 2017-02-16
2015-03-3139.17K shares
10-Q · filed 2015-05-07
283.43K shares
derived: sum of 2 quarters · filed 2017-02-16
539.57K shares
derived: sum of 3 quarters · filed 2017-02-16
578.70K shares
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31244.26K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
500.40K shares
derived: sum of 2 quarters · filed 2017-02-16
539.53K shares
derived: sum of 3 quarters · filed 2017-02-16
727.80K shares
10-K · filed 2017-02-16
2014-09-30256.13K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
295.27K shares
derived: sum of 2 quarters · filed 2014-10-30
483.54K shares
10-Q · filed 2014-10-30
564.90K shares
derived: sum of 4 quarters · filed 2016-02-24
2014-06-3039.13K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
227.40K shares
10-Q · filed 2014-08-07
308.77K shares
derived: sum of 3 quarters · filed 2016-02-24
1.13M shares
derived: sum of 4 quarters · filed 2016-02-24
2014-03-31188.27K shares
10-Q · filed 2014-05-08
269.63K shares
derived: sum of 2 quarters · filed 2016-02-24
1.09M shares
derived: sum of 3 quarters · filed 2016-02-24
2.61M shares
derived: sum of 4 quarters · filed 2016-02-24
2013-12-3181.37K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
899.62K shares
derived: sum of 2 quarters · filed 2016-02-24
2.42M shares
derived: sum of 3 quarters · filed 2016-02-24
2.48M shares
10-K · filed 2016-02-24
2013-09-30818.25K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22
2.34M shares
derived: sum of 2 quarters · filed 2013-10-22
2.40M shares
10-Q · filed 2013-10-22
2.41M shares
derived: sum of 4 quarters · filed 2015-02-26
2013-06-301.52M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
1.58M shares
10-Q · filed 2013-08-08
1.60M shares
derived: sum of 3 quarters · filed 2015-02-26
1.71M shares
derived: sum of 4 quarters · filed 2015-02-26
2013-03-3161.20K shares
10-Q · filed 2013-05-07
76.33K shares
derived: sum of 2 quarters · filed 2015-02-26
195.30K shares
derived: sum of 3 quarters · filed 2015-02-26
2012-12-3115.13K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
134.10K shares
derived: sum of 2 quarters · filed 2015-02-26
292.53K shares
10-K · filed 2015-02-26
2012-09-30118.97K shares
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-08
277.40K shares
10-Q · filed 2012-11-08
2012-06-30158.43K shares
10-Q/A · filed 2012-08-28
2011-12-31843.08K shares
10-K · filed 2014-03-03
2010-12-3164.58K shares
10-K · filed 2013-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02